Samira Mubareka

TL;DR: Diagnostic and surveillance technologies for SARS-CoV-2 and their performance characteristics are described and point-of-care diagnostics that are on the horizon are described to encourage academics to advance their technologies beyond conception.

TL;DR: It is confirmed that serum and saliva IgG antibodies to SARS-CoV-2 are maintained in the majority of COVID-19 patients for at least 3 months PSO, and IgG responses in saliva may serve as a surrogate measure of systemic immunity to Sars-Cov-2 based on their correlation with serum IgG responds.

TL;DR: The lack of aerosol transmission at 30°C and at all humidities tested implies that contact or short-range spread predominates in the tropics and offers an explanation for the lack of a well-defined, recurrent influenza season affecting tropical and subtropical regions of the world.

TL;DR: In this article, the authors evaluated the impact of prospective audit and feedback on broad-spectrum antimicrobial use among critical care patients, and found that broad spectrum antibiotic use decreased from 644 days of therapy per 1,000 patient-days in the preintervention period to 503 days of antibiotic therapy per 1000 patient-day in the postintervention periods (P <.0001).

TL;DR: This data indicates that difference in sensitivity was greatest for sample pairs collected later in illness, and COVID-19 was recommended as a first line treatment for severe acute respiratory syndrome coronavirus 2.